In case you missed them.
An interesting new article finds that Bacterioides fragilis toxin induces a pro-carcinogenic signaling relay from the colonic epithelial cells to a mucosal Th17 response that results in myeloid-cell-dependent distal colon tumorigenesis #ToxTuesday https://t.co/fCAWDRWdrq— INDS, Inc. (@INDSInc) February 6, 2018
You may know Frances Oldham Kelsey as the woman who stopped thalidomide from being approved in the US in 1960, but did you know she also identified the poisonous component of Elixir Sulfanilamide (diethylene glycol) in the 1930s? #ToxTuesday https://t.co/fxnIJ7222k— INDS, Inc. (@INDSInc) February 13, 2018
Clostridium difficile is a deadly bacterium that thrives in hospitals, a @UMich researcher helped to create an algorithm to predict a patient's risk of developing a C-diff infection #ToxTuesday https://t.co/zCGA005tVz— INDS, Inc. (@INDSInc) February 20, 2018
In honor of #RareDiseaseDay tomorrow (Feb 28th) - take a look at the February issue of @PharmaVOICE. 350 million people worldwide are living with a rare disease! Many of our consulting projects deal in the rare disease space #ToxTuesday https://t.co/8xhLCdaq9B— INDS, Inc. (@INDSInc) February 27, 2018